Poultry Diagnostics Market Report 2026

The poultry diagnostics market size has grown rapidly in recent years. It will grow from $0.69 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to frequent outbreaks of avian diseases, rising poultry population, limited access to advanced diagnostics, growing demand for poultry products, expansion of veterinary healthcare infrastructure.

The poultry diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to technological advancements in poultry diagnostics, increasing adoption of automated diagnostic instruments, rising awareness of preventive poultry healthcare, integration of digital farm management with diagnostics, growth of rapid and point-of-care testing solutions. Major trends in the forecast period include rising adoption of pcr and elisa-based diagnostic technologies, increasing use of rapid test kits for early disease detection, expansion of poultry disease surveillance programs, growing focus on biosecurity and preventive healthcare in poultry, integration of veterinary diagnostic services with farm management systems.

The increasing incidence of poultry diseases is expected to drive the growth of the poultry diagnostics market going forward. Poultry diseases encompass various health issues affecting domesticated birds raised for meat, eggs, or feathers. These diseases can severely impact poultry health and productivity, resulting in economic losses for the poultry industry. The rise in poultry disease incidence is attributed to factors such as intensive farming practices, nutritional deficiencies, environmental stressors, and emerging pathogens. Poultry diagnostics plays a critical role in addressing this challenge by enabling early detection, ensuring product safety, supporting research, and enhancing understanding of flock health, thereby contributing significantly to the sustainability and productivity of the poultry industry. For example, in April 2025, according to the World Organisation for Animal Health (WOAH), a France-based intergovernmental animal health body, 949 outbreaks of highly pathogenic avian influenza (HPAI) in poultry were reported globally between October 2024 and February 2025, exceeding the total number of outbreaks recorded in the previous season and highlighting an intensifying global trend in poultry disease incidence. Therefore, the growing incidence of poultry diseases is driving the growth of the poultry diagnostics market.

Leading companies in the poultry diagnostics market are focusing on developing innovative products such as test reagents to improve the efficiency and accuracy of poultry health diagnostics. Specifically, these reagents detect robenidine, an anticoccidial agent used to prevent coccidiosis in poultry. Test reagents are specialized tools for detecting robenidine residues in poultry meat and organs, crucial for ensuring food safety and regulatory compliance. For instance, in October 2024, Creative Diagnostics, a US-based company, introduced Rapid Robenidine Test Reagents. These reagents are designed to quickly and accurately identify robenidine in poultry and other samples, helping ensure compliance with safety and quality standards.

In March 2024, HatchTech Group, a Netherlands-based company specializing in innovative poultry incubation systems, acquired NYtor for an undisclosed amount. This acquisition aims to enhance HatchTech’s capabilities in providing advanced, data-driven solutions for poultry incubation. NYtor B.V., also based in the Netherlands, offers advanced diagnostic and monitoring solutions across various industries, including poultry.

Major companies operating in the poultry diagnostics market are IDEXX Laboratories Inc., Thermo Fisher Scientific Inc., Zoetis Inc., BioMérieux SA, Bio‑Rad Laboratories Inc., QIAGEN NV, Neogen Corporation, GD Animal Health, Innovative Diagnostics SAS, MEGACOR Diagnostik GmbH, BioChek BV, Ring Biotechnology Co Ltd, Agrolabo SpA, IDvet, Bionote Inc., Bio‑X Diagnostics, Biogal Galed Labs, AffiniTech Ltd, Randox Laboratories Ltd, INDICAL Bioscience GmbH, Bioneer Corporation, Antech Diagnostics Inc., Embark Veterinary Inc., Merck Animal Health, Meridian Bioscience Inc., Biodyne USA LLC, Avioq Inc., AniCon Labor GmbH.

North America was the largest region in the poultry diagnostics market in 2025. The regions covered in the poultry diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the poultry diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the poultry diagnostics market by increasing the cost of imported instruments, diagnostic kits, and consumables such as PCR and ELISA reagents. Segments including PCR machines, immunoassay analyzers, and serological kits are most affected, with regions like North America and Europe facing higher cost pressures due to reliance on imports. While tariffs create challenges in operational expenses, they also promote local manufacturing, innovation in low-cost diagnostic solutions, and development of regionally optimized poultry testing kits.

The poultry diagnostics market research report is one of a series of new reports that provides poultry diagnostics market statistics, including poultry diagnostics industry global market size, regional shares, competitors with a poultry diagnostics market share, detailed poultry diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the poultry diagnostics industry. This poultry diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Poultry diagnostics involves the identification and analysis of diseases, infections, and health issues in poultry such as chickens, turkeys, and ducks. The primary aim of poultry diagnostics is to maintain the health and productivity of poultry flocks by accurately diagnosing and addressing diseases, preventing illness spread, and ensuring the safety of poultry products.

Poultry diagnostics primarily comprises instruments, consumables, and kits. Instruments used in poultry diagnostics are specialized tools and devices designed to detect and diagnose diseases in poultry. Technologies used include enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), immunofluorescent assay, hemagglutination assay, and others. Diseases detected through these diagnostics include avian salmonellosis, avian influenza, Newcastle disease, mycoplasma, infectious bursal disease, and more. These diagnostic tools are utilized by various end-users, including veterinary hospitals and clinics, veterinary diagnostics laboratories, and other relevant entities.

The poultry diagnostics market consists of revenues earned by entities by providing Clinical Examination, Microbiological Testing, Serological Testing, Histopathology, Imaging Techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. The poultry diagnostics market also includes sales of microscopes, diagnostic test kits, culturing equipment, imaging equipment, and blood analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.